CAS: 1254036-71-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 1H-Indazole, 6-(1H-indol-4-yl)-4-[5-[[4-(1-methylethyl)-1-piperazinyl]methyl]-2-oxazolyl]- REF: IN-DA000NMTCAS: 1254036-71-9 | 99.80% | A consultar | Mar 03 Dic 24 |
 | Nemiralisib REF: 3D-EAC03671CAS: 1254036-71-9 | Min. 95% | A consultar | Mar 14 Ene 25 |
 | Nemiralisib REF: TM-T15431CAS: 1254036-71-9 | 99.91% | 48,00 €~449,00 € | Mar 21 Ene 25 |
![1H-Indazole, 6-(1H-indol-4-yl)-4-[5-[[4-(1-methylethyl)-1-piperazinyl]methyl]-2-oxazolyl]-](https://static.cymitquimica.com/products/IN/thumb/DA000NMT.jpg)
1H-Indazole, 6-(1H-indol-4-yl)-4-[5-[[4-(1-methylethyl)-1-piperazinyl]methyl]-2-oxazolyl]-
CAS:1254036-71-9
Fórmula:
C26H28N6O
Pureza:
99.80%
Forma y color:
Solid
Peso molecular:
440.5401
Ref: IN-DA000NMT
| 5mg | 333,00 € | ||
| 10mg | 537,00 € | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 3 de Diciembre de 2024
Nemiralisib
CAS:1254036-71-9
Nemiralisib is a small molecule that inhibits the PD-L1 protein. It can be used to …
Fórmula:
C26H28N6O
Pureza:
Min. 95%
Peso molecular:
440.54 g/mol
Ref: 3D-EAC03671
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
Nemiralisib
CAS:1254036-71-9
Nemiralisib (GSK-2269557) is an oral PI3Kδ inhibitor (pKi 9.9) for treating respiratory diseases like COPD.
Fórmula:
C26H28N6O
Pureza:
99.91%
Forma y color:
Solid
Peso molecular:
440.54
Ref: TM-T15431
| 1mg | 48,00 € | ||
| 2mg | 61,00 € | ||
| 5mg | 89,00 € | ||
| 10mg | 144,00 € | ||
| 25mg | 280,00 € | ||
| 50mg | 449,00 € | ||
| 1mL*10mM (DMSO) | 98,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
